Stablecoin Development (SDEV) vs Unicycive Therapeutics (UNCY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Unicycive Therapeutics (UNCY) has outperformed Stablecoin Development (SDEV) over the past year, losing 9.7% versus a loss of 55.9%. Over five years, UNCY leads with a -84.7% price change compared with -99.9% for SDEV. Unicycive Therapeutics is the larger company by market cap ($111.1 million vs $104.3 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | SDEV | UNCY |
|---|---|---|
| Share price | $2.02 | $4.06 |
| Market cap | $104.28M | $111.08M |
| 1-day change | -27.47% | -2.99% |
| YTD return | -90.14% | -27.56% |
| 1-year return | -55.87% | -9.72% |
| 5-year return | -99.92% | -84.65% |
| Forward P/E | — | 2.40 |
| EPS (TTM) | $-21.13 | $-1.72 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $99.75 | $8.74 |
| 52-week low | $0.78 | $3.93 |
| Distance from 52-week high | -97.98% | -53.60% |
| Average volume | 11.42M | 837.51K |
| Shares outstanding | 51.75M | 27.39M |
| Employees | 2 | — |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- UNCY has outperformed SDEV by 46.2 percentage points over the past year.
About Stablecoin Development
SDEV stock →Stablecoin Development Corporation engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment of SKY, a protocol token of the decentralized Sky Protocol.
Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees
SDEV vs UNCY FAQ
Which is bigger, Stablecoin Development or Unicycive Therapeutics?
Unicycive Therapeutics (UNCY) is larger, with a market capitalization of $111.08M compared with $104.28M for Stablecoin Development (SDEV).
Which stock has performed better over the past year, SDEV or UNCY?
UNCY returned -9.72% over the past 12 months, compared with -55.87% for SDEV (price return, excluding dividends). Past performance does not predict future results.
Are Stablecoin Development and Unicycive Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.